HEALTH SOLUTIONS
Medicaid
As a new federal law, effective in 2024, removes a cap on manufacturers' drug rebate amounts, we explore the implications for state Medicaid programs.
We review the essentials for states to consider regarding the proposed changes by CMS for Medicaid and Children’s Health Insurance Program Managed Care Access.
As drug costs continue to rise, states need to engage in strategies that include policy and nonpolicy options to manage prescription spending in Medicaid.
This report provides an analysis of the recently released 2021 Centers for Medicare and Medicaid Services (CMS) Medicaid and Children’s Health Insurance Program (CHIP) Scorecard.
Uncertainty remains regarding COVID-19’s impact on Medicaid MCO financial performance, including the deferral of care, pent-up demand, and future claims.
A summary of available data sources that can assist state Medicaid agencies in evaluating health disparities and measuring progress toward health equity goals
Design and implementation of new care models mean a major undertaking for many plans, yet optimizing their value could bring substantial rewards for MCOs.
The COVID-19 pandemic presents unique challenges for Medicaid Home and Community-Based Services program participants.
This brief scopes out the issue of homelessness and housing security and Medicaid’s role in addressing the issue.
This report provides an analysis of the recently released 2020 Centers for Medicare and Medicaid Services (CMS) Medicaid and Children’s Health Insurance Program (CHIP) Scorecard.
